Clinical Trials

20 enrolled

Carcinoma, Ovarian Epithelial

NCT05077215 2025-12-08

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

450 enrolled

Advanced Endometrial Cancer

NCT05106127 2025-12-08

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

28 enrolled

Advanced Endometrial Cancer

NCT07230626 2025-11-17

SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

412 enrolled

Phase 2/3 Not yet recruiting

Uterine Cervical Neoplasms

NCT07219238 2025-10-21

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

175 enrolled

GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07177716 2025-09-17

Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer

Phase 2/3 Not yet recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT07124793 2025-08-15

A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors

Phase NA Not yet recruiting

60 enrolled

GynecologicThoracic

EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer

NCT06634706 2025-08-13

SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors

96 enrolled

GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms

NCT07088588 2025-07-28

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Phase 4 Not yet recruiting

105 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

100 enrolled

Endometrial Neoplasms

NCT07044349 2025-06-30

Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

72 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06990971 2025-05-25

CYCLE_ENDO

Not yet recruiting

200 enrolled

Phase 4 Not yet recruiting

Endometriosis, Infertility, Endometrial Neoplasms, Adenomyosis

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

67 enrolled

Ovarian Neoplasms

NCT06867562 2025-03-10

Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

166 enrolled

Phase NA Not yet recruiting

Platinum-Resistant Primary Peritoneal Carcinoma

NCT06844097 2025-03-04

CC-Trained

60 enrolled

Clinical Competence

NCT06754761 2025-01-01

Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib

8 enrolled

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06751485 2024-12-31

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

430 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06748872 2024-12-27

EPITOME-1015-I

55 enrolled

GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT06730581 2024-12-12

Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors

GastrointestinalGynecologic

100 enrolled

Bile Duct Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06724263 2024-12-09

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

BreastGastrointestinalGynecologicThoracic

120 enrolled

Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06652529 2024-11-07

AROG4-01-01

GastrointestinalGynecologicOther solid neoplasmThoracic

35 enrolled

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06672653 2024-11-04

PREPAP

66 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06620029 2024-10-01

BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer

27 enrolled

Ovarian Neoplasms, Endometrial Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

BreastGastrointestinalGenitourinaryGynecologic

112 enrolled

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06531486 2024-08-01

A Study of XS-02 Capsules in Patients With Advanced Solid Tumors

96 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06519110 2024-07-25

CVL009-C2001

GastrointestinalGynecologicHead & NeckThoracic

60 enrolled

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Salivary Gland Neoplasms, Cholangiocarcinoma

NCT06283875 2024-07-18

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

Not yet recruiting

80 enrolled

Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

GastrointestinalGenitourinaryGynecologicHead & Neck

66 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06475599 2024-06-27

Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer

420 enrolled

Endometrial Neoplasms

NCT06358053 2024-04-10

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers